Xenon Pharma CEO Ian Mortimer acquires $1,121,400 in common shares
XENE•Xenon Pharmaceuticals President and CEO Ian Mortimer bought 30,000 common shares at $37.38 each, worth $1,121,400. His directly held stake rose to 49,923 shares; 14,300 additional shares were reported as indirectly held by his spouse.
1. Share purchase
Ian Mortimer bought 30,000 Xenon Pharmaceuticals common shares at $37.38 each. Following the purchase, his directly held stake rose to 49,923 common shares. An additional 14,300 common shares were reported as indirectly held by his spouse.
